In course of five months and three education modules of the program, regional teams along Russian and leading international experts on public administration were developing projects on the enhancement of investment climate and investment raising.
The project competition panel included Aleksandr Idrisov, President of Strategy Partners Group, Aleksandr Tsybulskiy, Deputy Minister of Economic Development, Sergey Nedoroslev, Chairman of Kaskol Group, Konstantin Abramov, Chairman of Russian Public Opinion Research Center VCIOM, Dmitriy Butashin, vice-rector of RPANEPA and other experts.
The project of the Tomsk Region aimed to create and investment chain in “pharmacy, medical equipment and IT in healthcare” was named the best innovative project. The panel awarded the Tomsk Region’s team with the grand prize of the project contest.
“The team of the Tomsk Region has stated an ambitions objective for their region – to become a globally recognizable player in the sector of “pharmacy, medical equipment and IT in healthcare” and developed an ambitious project. The project is based on the region’s competitive advantages and creates opportunities for attracting investment into new sectors of economy”, - Aleksandr Idrisov, Chairman of the expert panel, noted.
In the center of the Tomsk Region’s project is translational medicine – a chain from idea to the final product in the form of a device or a drug. Nowadays, one of the most important directions is the reduction of the time, cost and improvement of the quality of new medical technology and products. The leading regions of Russia and foreign countries are focusing their efforts to achieve that.
“The achievement of the Tomsk Region’s team is that we looked at the translation medicine chain as an investment one. We saw specific objectives for regional authorities and proposed a federal initiative”, - said the team leader Andrey Antonov, Deputy Governor of the Tomsk Region for economy.
The team proposed a federal initiative to create the new section in the National Investment Climate Rankings for new economy sectors to facilitate the attraction of investment into the regions that focus on hi-tech industries. Important for such sectors is not only connection to utilities and the time it takes to get a construction permit, but also special factors such as concentration of specific business in the area, availability of labor resources with required qualification, the quality of regional legislation on intellectual property protection, availability of internationally certified infrastructure (SPF-vivarium, molecule and cell bank), etc. Such new rating will enable the attraction of investors to the development of hi-tech economy sectors in the regions of Russia. In the nearest future, the initiative will be discussed with the Agency for Strategic Initiatives, and at the meeting of the federal task team on the implementation of the “INO Tomsk” Concept.
As of today in Russia, various stages of the translational chain are supervised by different ministries. As a result, individual stages do not focus on the product, the stage indicators are not correlated and the financing is unbalanced. To eliminate the inter-agency barriers and to avoid projects’ “getting stuck” at various stages of implementation (pre-clinical and clinical trials, implementation in the clinical practice, product manufacturing) the Tomsk Region is to create the Coordinating Council on the development of translational medicine. It will include representatives from the Ministry of Industry and Trade, Ministry of Healthcare, Ministry of Education and Science, Federal Agency of Scientific Organizations, companies, universities and scientific organizations.
To improve competitiveness at the stage of fundamental and pre-clinical research, it is necessary to unite the competences of Tomsk universities and scientific organizations within joint integrated projects, including federal ones. The team of the Tomsk Region has studied the experience and the infrastructure of Russian regions and their specialization related to translational medicine. The next step is joint projects with the regions to form the so-called “pre-market” consortiums that allow carrying out of research to create a new line of medical products.
To develop translational medicine in the Tomsk Region, it is necessary to boost the support of leading regional companies and attract investors to new technological solutions. The region plans to create a specialized service to work with in-house and external investors in translational medicine. The objective of the service is to offer to an investor a most transparent path from research to new product, find scientific partners, provide special infrastructure, and coordinate institutional support mechanisms.
The implementation of the project in the Tomsk Region will help reduce the time it takes to create new drugs and medical equipment, and increase investment efficiency.